SQUAMOUS CELL CARCINOMA OF THE BLADDER
Clinical trials for SQUAMOUS CELL CARCINOMA OF THE BLADDER explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA OF THE BLADDER trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA OF THE BLADDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare, aggressive cancers as national trial tests promising drug duo
Disease control Recruiting nowThis study is testing whether two existing cancer drugs, sacituzumab govitecan and atezolizumab, can help control rare and aggressive cancers of the bladder, urinary tract, kidney, and penis. The trial will enroll 60 adults to receive one or both drugs, given through an IV, to se…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE BLADDER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New hope for rare cancers: testing approved drugs on tough tumors
Disease control Recruiting nowThis study is testing whether a combination of two drugs, already approved for some common bladder cancers, can help control rare types of urinary tract and testicular cancers. It will involve about 68 adults whose cancer has spread and who have few other treatment options. The g…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE BLADDER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC